COMPOSITION FOR ALLEVIATING OR TREATING PAIN

Citrus reticulata blanco plant named `Tamdori'

A new and distinct Citrus Reticulate Blanco plant named ‘Tamdori’, characterized by its upright plant type and strong vigor, fertile but self-incompatibility pollen, orange fruit color, germination stage in middle of April, blooming stage in late May, fruits start coloring in late October and finish coloring in late December, mature stage in middle of February, fruit weight at about 168.9 g, fruit skin thickness at about 2.3 mm and easy to peel, fruit flesh rate at about 79.9%.

DISPLAY PANEL AND DISPLAY APPARATUS INCLUDING THE SAME

A display panel includes: a substrate including a first area, a second area, and a third area located between the first area and the second area; a display layer including a display element located in the second area; a first metal layer located in the third area; an organic insulating layer located on the first metal layer and including at least one contact portion; and a second metal layer located on the organic insulating layer and contacting the first metal layer through the at least one contact portion, in which the second metal layer has a first hole, and the organic insulating layer has a second hole or a first recess corresponding to the first hole, and a residual layer located in the second hole or the first recess and including a part of at least one organic layer overlaps the first metal layer. 1. A display panel comprising:a substrate comprising a first area, a second area, and a third area located between the first area and the second area;a display layer comprising a pixel circuit located in the second area and a display element electrically connected to the pixel circuit, the display element comprising a pixel electrode, a counter electrode, and an intermediate layer located between the pixel electrode and the counter electrode and comprising an emission layer and at least one organic layer;a first metal layer located in the third area;an organic insulating layer located on the first metal layer and comprising at least one contact portion; anda second metal layer located on the organic insulating layer and contacting the first metal layer through the at least one contact portion,wherein the second metal layer has a first hole, and the organic insulating layer has a second hole or a first recess corresponding to the first hole, anda residual layer located in the second hole or the first recess and including a part of the at least one organic layer overlaps the first metal layer.2. The display panel of claim 1 , further comprising an inorganic ...

RECOMBINANT VACCINIA VIRUS AND USE THEREOF

DISPLAY PANEL INCLUDING AREA FOR COMPONENT INSIDE DISPLAY AREA AND DISPLAY APPARATUS INCLUDING THE SAME

A display panel includes: a substrate including a first area, a second area, and a third area located between the first area and the second area; a display layer including a display element located in the second area; a first metal layer located in the third area; an organic insulating layer located on the first metal layer and including at least one contact portion; and a second metal layer located on the organic insulating layer and contacting the first metal layer through the at least one contact portion, in which the second metal layer has a first hole, and the organic insulating layer has a second hole or a first recess corresponding to the first hole, and a residual layer located in the second hole or the first recess and including a part of at least one organic layer overlaps the first metal layer.

METHOD OF CLEAVING SUBSTRATE AND METHOD OF MANUFACTURING BONDED SUBSTRATE USING THE SAME

A method of cleaving a substrate and a method of manufacturing a bonded substrate using the same, in which warping in a cleaved substrate is reduced. The method includes the following steps of: forming an ion implantation layer by implanting ions into a substrate; annealing the substrate in which the ion implantation layer is formed; implanting ions again into the ion implantation layer of the substrate; and cleaving the substrate along the ion implantation layer by heating the substrate into which ions are implanted. 1. A method of cleaving a substrate , comprising:a first ion implantation step of forming an ion implantation layer by implanting ions into the substrate;an annealing step of annealing the substrate;a second ion implantation step of implanting ions again into the ion implantation layer of the substrate; anda cleaving step of cleaving the substrate along the ion implantation layer by heating the substrate.2. The method of claim 1 , wherein the annealing step and the second ion implantation step in turn are repeated multiple times.3. The method of claim 1 , wherein the ions implanted in the first ion implantation step and the ions implanted in the second ion implantation step are ions of at least one selected from the group consisting of hydrogen claim 1 , helium claim 1 , nitrogen claim 1 , oxygen and argon.4. The method of claim 1 , wherein the annealing step is carried out below a temperature at which the substrate is cleaved along ion implantation layer.5. A method of manufacturing a cleaved substrate claim 1 , comprising:forming an ion implantation layer by implanting ions into a compound semiconductor substrate;annealing the compound semiconductor substrate;implanting ions again into the ion implantation layer of the compound semiconductor substrate;preparing a bonded substrate by bonding the compound semiconductor substrate to a carrier substrate; andcleaving the compound semiconductor substrate along the ion implantation layer by heating the ...

Organic light emitting diode display device and method of manufacturing the same

Disclosed are an organic light emitting diode (OLED) display device and a method of manufacturing the same, which can simplify a manufacturing process and decrease an error. The OLED display device includes a substrate on which an organic light emitting diode (OLED) is formed, a first inorganic thin layer configured to cover the OLED, an organic deposition layer configured to have an organic layer characteristic covering the first inorganic thin layer, and a second inorganic thin layer configured to cover the organic deposition layer.

Substrate For Vertical Light-Emitting Diode

A multi-layer substrate for a vertical light-emitting diode (LED) includes a conductive and reflective base substrate and an n-type gallium nitride (GaN) layer formed on the base substrate. 1. A multi-layer substrate for a vertical light-emitting diode , comprising:a conductive and reflective base substrate; andan n-type gallium nitride (GaN) layer formed on the base substrate.2. The multi-layer substrate of claim 1 , wherein the base substrate comprises a single layer.3. The multi-layer substrate of claim 1 , whereinthe base substrate comprises a conductive layer and a reflective layer formed on the conductive layer, andthe n-type gallium nitride (GaN) layer is formed on the reflective layer.4. The multi-layer substrate of claim 3 , further comprising:a bonding layer interposed between the conductive layer and the reflective layer; andan anti-diffusion layer interposed between the bonding layer and the reflective layer.5. The multi-layer substrate of claim 3 , wherein the conductive layer comprises one selected from the group consisting of Si claim 3 , GaAs claim 3 , GaP claim 3 , AlGaINP claim 3 , Ge claim 3 , SiSe claim 3 , GaN claim 3 , AlInGaN and InGaN.6. The multi-layer substrate of claim 3 , wherein the conductive layer comprises one selected from the group consisting of Al claim 3 , Zn claim 3 , Ag claim 3 , W claim 3 , Ti claim 3 , Ni claim 3 , Au claim 3 , Mo claim 3 , Pt claim 3 , Pd claim 3 , Cu claim 3 , Cr claim 3 , Fe and alloys thereof.7. The multi-layer substrate of claim 3 , wherein the reflective layer comprises one selected from the group consisting of Ag claim 3 , Al claim 3 , Zn claim 3 , Au claim 3 , Pt claim 3 , Ti claim 3 , Ge claim 3 , Cu and Ni.8. The multi-layer substrate of claim 1 , wherein a reflectance of the base substrate is 50% or greater with respect to light that has a wavelength of 300 μm or greater.9. The multi-layer substrate of claim 1 , wherein a coefficient of thermal expansion of the base substrate ranges from 2.5 to 7.5. ...

Bonded Substrate And Method Of Manufacturing The Same

A bonded substrate, the surface roughness of which is reduced, and a method of manufacturing the same. The bonded substrate includes a base substrate and an intermediate layer disposed on the base substrate. The intermediate layer has a greater bubble diffusivity than the base substrate. A thin film layer is bonded onto the intermediate layer, and has a different chemical composition from the base substrate.

Bonded substrate and method of manufacturing the same

A bonded substrate having a plurality of grooves and a method of manufacturing the same. The method includes the following steps of implanting ions into a first substrate, thereby forming an ion implantation layer, bonding the first substrate to a second substrate having a plurality of grooves in one surface thereof such that the first substrate is bonded to the one surface, and cleaving the first substrate along the ion implantation layer.

Method Of Manufacturing Thin-Film Bonded Substrate Used For Semiconductor Device

A method of manufacturing a thin-film bonded substrate used for semiconductor devices. The method includes the steps of epitaxially growing an epitaxial growth layer on a first substrate of a bulk crystal, cleaving the first substrate, thereby leaving a crystal thin film on the epitaxial growth layer, the crystal thin film being separated out of the first substrate, and bonding a second substrate to the crystal thin film, the chemical composition of the second substrate being different from the chemical composition of the first substrate. It is possible to preclude a conductive barrier layer of the related art, prevent a reflective layer from malfunctioning due to high-temperature processing, and essentially prevent cracks due to the difference in the coefficients of thermal expansion between heterogeneous materials that are bonded to each other. 1. A method of manufacturing a thin-film bonded substrate used for a semiconductor device , the method comprising:epitaxially growing an epitaxial growth layer on a first substrate of a bulk crystal;cleaving the first substrate, thereby leaving a crystal thin film on the epitaxial growth layer, the crystal thin film being separated out of the first substrate; andbonding a second substrate to the crystal thin film, a chemical composition of the second substrate being different from a chemical composition of the first substrate.2. The method of claim 1 , wherein cleaving the first substrate comprises bonding a third substrate to the epitaxial growth layer before cleaving the first substrate.3. The method of claim 2 , further comprising claim 2 , after bonding the second substrate to the crystal thin film claim 2 , removing the third substrate.4. The method of claim 2 , wherein the epitaxial growth layer and the third substrate are bonded to each other via an adhesive.5. The method of claim 2 , wherein the epitaxial growth layer and the third substrate are directly bonded to each other via heating and pressing.6. The method of ...

DIAMINE COMPOUND, AND POLYIMIDE PRECURSOR AND POLYIMIDE FILM USING SAME

Disclosed is a novel diamine compound in which an imide ring is directly bonded to a (hetero)aryl ring in a molecule, and a polyimide film prepared by polymerizing the novel diamine compound exhibits improved thermal properties and storage stability. 3. The diamine compound according to claim 1 , wherein L in the formula 1 is phenyl which is unsubstituted or substituted with one or more substituents selected from the group consisting of trifluoromethyl claim 1 , methyl claim 1 , chlorine (Cl) and methoxy; biphenyl which is unsubstituted or substituted with one or more substituents selected from the group consisting of methyl claim 1 , trifluoromethyl and chlorine (Cl); terphenyl which is unsubstituted or substituted with trifluoromethyl; bis(trifluoromethylphenyl)sulfone claim 1 , bis(methylphenyl)sulfone claim 1 , {(trifluoromethylphenyl)sulfonyl}phenyl claim 1 , diphenylsulfide claim 1 , bis(methylphenyl)sulfide claim 1 , bis(trifluoromethylphenyl)sulfide or diphenyl ether claim 1 ,{'sub': 1', '2, 'Arand Arare each independently phenyl which is unsubstituted or substituted with one or more substituents selected from the group consisting of methyl, trifluoromethyl and chlorine (Cl),'}l is an integer of 0 to 2, andm, n, o, p, q, r, s and t are each an integer of 0 or 1.5. A polyimide precursor comprising a polymerized product of a composition comprising the diamine compound of formula 1 according to and at least one acid dianhydride.6. The polyimide precursor according to claim 5 , wherein the acid anhydride comprises BPDA (biphenyl-tetracarboxylic acid dianhydride) claim 5 , 6-FDA (4 claim 5 ,4′-(hexafluoroisopropylidene)diphthalic anhydride) or a mixture thereof.7. A polyimide film formed from the polyimide precursor according to .8. A flexible device including the polyimide film according to as a substrate.9. A polyimide precursor comprising a polymerized product of a composition comprising the diamine compound of formula 1 according to and at least one acid ...

OLED PANEL BOTTOM PROTECTION FILM, AND ORGANIC LIGHT-EMITTING DISPLAY DEVICE COMPRISING SAME

A bottom protection film for an OLED panel is provided. More particularly, a bottom protection film for an OLED panel, which has excellent alignment process workability and excellent adhesion to an OLED panel, and is capable of preventing static electricity through an antistatic treatment and preventing an electrical short circuit at the same time, and an organic light-emitting display device including the bottom protection film are provided. 3. The bottom protection film for an OLED panel of claim 1 , wherein a surface resistance of the first adhesive layer is 1.0×10to 1.0×10Ω/sq claim 1 ,{'sup': 5', '9, 'a surface resistance of the first base material is 1.0×10to 1.0×10Ω/sq, and'}{'sup': 5', '9, 'b': 1', '0', '10, 'surface resistances of the upper and lower surfaces of the liner film are each 1.0×10to .×Ω/sq, and'}{'sup': 5', '9, 'surface resistances of the second adhesive layer and the second base material are each 1.0×10to 1.0×10Ω/sq.'}4. The bottom protection film for an OLED panel of claim 1 , wherein the liner film has a release force of 5 gf/in or less.5. The bottom protection film for an OLED panel of claim 1 , wherein adhesion of the first adhesive layer measured by utilizing a measurement method below is 250 gf/in or higher:wherein in the measurement method, the first adhesive layer is adhered to glass, and after 24 hours, an adhesion of the first adhesive layer is measured when the first adhesive layer is exfoliated at 180° at a rate of 5 mm per second.6. The bottom protection film for an OLED panel of claim 1 , wherein an exfoliation force between the base film and the carrier film is 3 to 10 gf/in.7. The bottom protection film for an OLED panel of claim 1 , wherein the first base material and the second base material are each a PET base material claim 1 , andthe first adhesive layer and the second adhesive layer are acrylic adhesive layers.8. The bottom protection film for an OLED panel of claim 1 , wherein a lower surface of the liner film is silicon ...

N-PHENYL-N'-PHENOXYCARBONYL-PHENYLSULFONHYDRAZIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to a N-phenyl-N′-phenoxycarbonyl-phenylsulfonhydrazide derivative with excellent inhibitory activity on PGEproduction, a method for preparing the same and a pharmaceutical composition comprising the same as an active ingredient. The present N-phenyl-N′-phenoxycarbonyl-phenylsulfonhydrazide derivative may be used effectively for preventing or treating inflammation, arthritis, high fever, pain, cancer, stroke or bone disease. 2. The N-phenyl-N′-phenoxycarbonyl-phenylsulfonhydrazide derivative according to or pharmaceutically acceptable salt thereof claim 1 ,wherein,{'sup': '1', 'sub': 1', '6, 'Ris hydrogen or C-Calkyl,'}{'sup': '2', 'sub': 1', '6', '1', '6', '1', '6, 'Ris C-Calkyl, C-Calkoxy, halogen, C-Chaloalkyl or aryl,'}{'sup': '3', 'sub': 1', '6, 'Ris hydrogen or C-Calkyl,'}{'sup': '4', 'sub': 1', '6, 'Ris hydrogen or C-Calkoxy,'}{'sup': '5', 'Ris hydrogen, and'}{'sup': '6', 'sub': 1', '6', '1', '6, 'Ris hydrogen, C-Calkyl, C-Calkoxy or aryloxy, or'}{'sup': 5', '6, 'Rand Rare taken together with the carbon atom to which they are attached to form a 4 to 7-membered hydrocarbon ring.'}3. The N-phenyl-N′-phenoxycarbonyl-phenylsulfonhydrazide derivative according to or pharmaceutically acceptable salt thereof claim 1 ,wherein,{'sup': '1', 'Ris hydrogen or methyl,'}{'sup': '2', 'Ris methyl, n-propyl, i-propyl, t-butyl, methoxy, chloro, trifluoromethyl or phenyl,'}{'sup': '3', 'Ris hydrogen or methyl,'}{'sup': '4', 'Ris hydrogen or methoxy,'}{'sup': '5', 'Ris hydrogen, and'}{'sup': '6', 'Ris hydrogen, methyl, ethyl, methoxy, ethoxy, phenoxy or benzyloxy, or'}{'sup': 5', '6, 'Rand Rare taken together with the carbon atom to which they are attached to form a 5-membered hydrocarbon ring.'}4. The N-phenyl-N′-phenoxycarbonyl-phenylsulfonhydrazide derivative according to or pharmaceutically acceptable salt thereof selected from the group consisting of the following compounds:N-phenyl-N′-(4-methoxyphenoxycarbonyl)-4-methoxyphenylsulfonhydrazide (I ...

ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME

Discussed are an organic light emitting diode (OLED) display device and a method of manufacturing the same, which can simplify a manufacturing process and decrease an error. The OLED display device includes a substrate on which an organic light emitting diode (OLED) is formed, a first inorganic thin layer configured to cover the OLED, an organic deposition layer configured to have an organic layer characteristic covering the first inorganic thin layer, and a second inorganic thin layer configured to cover the organic deposition layer. 1. An organic light emitting diode (OLED) display device comprising:an organic light emitting diode (OLED) formed on a substrate;a first inorganic thin layer configured to cover the OLED;an organic deposition layer configured to have an organic layer characteristic covering the first inorganic thin layer; anda second inorganic thin layer configured to cover the organic deposition layer,wherein the first inorganic thin layer, the organic deposition layer, and the second inorganic thin layer are formed by the same process.2. The OLED display device of claim 1 , wherein a thickness of the organic deposition layer is 1 μm to 10 μm.3. The OLED display device of claim 1 , wherein the organic deposition layer has a double-layer structure claim 1 , andwherein a first layer of the organic deposition layer is formed to 70% or less of a total thickness of the organic deposition layer, and a second layer of the organic deposition layer is formed to 30% or more of a total thickness of the organic deposition layer.4. A method of manufacturing an organic light emitting diode (OLED) display device claim 1 , the method comprising:forming an organic light emitting diode (OLED) on a substrate;forming a first inorganic thin layer to cover the OLED;forming an organic deposition layer having an organic layer characteristic to cover the first inorganic thin layer; andforming a second inorganic thin layer to cover the organic deposition layer,wherein the ...

Method for delivery of biological molecule to nervous tissue

A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.

Semiconductor substrate measuring apparatus, semiconductor substrate processing apparatus and semiconductor device manufacturing method using the same

A semiconductor substrate processing apparatus includes a transfer chamber disposed between process chambers performing processing of a semiconductor substrate, a transfer robot disposed inside the transfer chamber to load the semiconductor substrate into the process chamber and unload the semiconductor substrate whose processing has been performed in the process chamber, an optical assembly irradiates irradiation light having multiple wavelengths onto the semiconductor substrate, the optical assembly splitting measurement light reflected from a surface of the semiconductor substrate into first and second measurement light and collecting interference light caused by first reflected light and second reflected light, a light detector detecting the interference light and converting the interference light into an electric signal to produce an interference signal, and a controller extracting spectrum information for each wavelength of the measurement light from the interference signal and calculating distribution information of a film formed on the semiconductor substrate.

Integrated circuit device

An integrated circuit device including a substrate including first and second device regions; a first fin active region on the first device region; a second fin active region on the second device region; an isolation film covering side walls of the active regions; gate cut insulating patterns on the isolation film on the device regions; a gate line extending on the fin active regions, the gate line having a length limited by the gate cut insulating patterns; and an inter-region insulating pattern on the isolation film between the fin active regions and at least partially penetrating the gate line in a vertical direction, wherein the inter-region insulating pattern has a bottom surface proximate to the substrate, a top surface distal to the substrate, and a side wall linearly extending from the bottom to the top surface.

CROSS-LINKING AGENT COMPOUND, LIQUID CRYSTAL ALIGNMENT COMPOSITION COMPRISING THE SAME, METHOD OF PREPARING LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING THE SAME

The present invention relates to a cross-linking agent compound of which end functional group is substituted with a protection group of a specific structure, a liquid crystal alignment composition comprising the cross-linking agent compound and polymer containing repeat units of polyimide or a precursor thereof, a method of preparing liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display using the same. 2. (canceled)3. The cross-linking agent compound according to claim 1 , whereinA is a C1-10 alkylene group or a C6-30 arylene group,p is 2, andn is 2.5. The cross-linking agent compound according to claim 1 , wherein{'sub': 1', '2, 'Land Lare identical to or different from each other, and each independently, a C1-5 alkylene group, and'}{'sub': 1', '2, 'Qand Qidentical to or different from each other, and each independently, a C1-10 alkyl group.'}6. The cross-linking agent compound according to claim 1 , wherein X is C or Si.8. A liquid crystal alignment composition comprising{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'the cross-linking agent compound of ; and'}a liquid crystal alignment polymer comprising one or more repeat units selected from polyamic acid repeat units, polyamic acid ester repeat units, and polyimide repeat units.10. The liquid crystal alignment composition according to claim 8 , comprising the cross-linking agent compound represented by the Chemical Formula 1 in an amount of 1 to 30 wt % claim 8 , based on the total weight of the liquid crystal alignment composition.11. A method for preparing a liquid crystal alignment film claim 8 , comprising steps of:{'claim-ref': {'@idref': 'CLM-00008', 'claim 8'}, 'applying the liquid crystal alignment composition of on a substrate to form a coating;'}drying the coating;irradiating light to the coating or rubbing the coating to progress alignment treatment; andheat treating the alignment-treated coating to cure.13. A liquid crystal alignment film comprising the ...

Electronic device and method for operating thereof

An electronic device is disclosed, and may include a communication circuit, a memory, and a processor operatively connected to the communication circuit and the memory. The memory stores instructions that, when executed, cause the processor to recognize a second external device that will perform an operation corresponding to a first utterance received by a first external device, to establish a first session between the first external device and the second external device, to recognize a device, which will perform an operation corresponding to a second utterance received by a third external device, while maintaining the first session, to determine whether to establish a second session between the third external device and the second external device based on a specified first condition when the device that will perform the operation corresponding to the second utterance is the second external device, and to establish the second session independently of the first session or establish an integrated session between the first external device, the second external device, and the third external device by integrating the first session and the second session when establishing the second session, on a basis of a specified second condition.

Display device and method for fabricating the same

A display device and a method of manufacturing the display device that is capable of easily bending the display device, simplifying manufacturing processes, and reducing manufacturing costs are provided. The display device includes a substrate including a bending area; a display element disposed on an upper surface of the substrate; and a protective layer disposed on a lower surface of the substrate. A portion of the protective layer that is disposed in the bending area has a material stiffness lower than a material stiffness of another portion of the protective layer.

Citrus reticulata blanco plant named 'TAMDO NO.3'

A new and distinct Citrus Reticulate Blanco plant named ‘Tamdo No. 3’, characterized by its upright plant type and strong vigor, The plant type of Tamdo No. 3 is upright and the tree vigor is strong, fruit shape is oblate and the fruit shape index is about 143, fruit skin thickness is about 2.7 mm so it is easy skinning, the fruit flesh rate is about 82.9%, sugar of fruit juice is about 13.7° Bx, the acidity is about 0.79%, and the sugar acid ratio is about 17.34.

COMPOSITION FOR TREATING PAIN

The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition. 1. A pharmaceutical composition for relieving or treating pain , which comprises a gene encoding glutamate decarboxylase (GAD) and a gene encoding interleukin-10 (IL-10).2. The composition of claim 1 , wherein the composition comprises a first vector operably containing a gene encoding GAD and a second vector operably containing a gene encoding IL-10.3. The composition of claim 2 , wherein the composition comprises a first vector containing a gene encoding GAD and a second vector containing a gene encoding IL-10 in a virus titer-based mixing ratio per unit volume of 1:1 to 1:50.4. The composition of claim 3 , wherein the vector is at least one viral vector selected from the group consisting of adenovirus claim 3 , adeno-associated virus claim 3 , herpes simplex virus claim 3 , lentivirus claim 3 , retrovirus and poxvirus.5. The composition of claim 1 , wherein the GAD is at least one selected from the group consisting of GAD65 and GAD67.6. The composition of claim 1 , wherein the GAD consists of the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 4.7. The composition of claim 1 , wherein the gene encoding GAD consists of the base sequence of SEQ ID NO: 2 claim 1 , SEQ ID NO: 3 or SEQ ID NO: 5.8. The composition of claim 1 , wherein the IL-10 consists of the amino acid sequence of SEQ ID NO: 6 or SEQ ID NO: 9.9. The composition of claim 1 , wherein the gene encoding IL-10 consists of the base sequence of SEQ ID NO: 7 claim 1 , SEQ ID NO: 8 or SEQ ID NO: 10.10. The composition of claim 1 , wherein the pain is nociceptive pain claim 1 , psychogenic pain claim 1 , inflammatory pain claim 1 , or pathological pain.11. The composition of claim 10 , wherein the pain is neuropathic pain claim 10 , cancer pain claim 10 , ...

Recombinant vaccinia virus and use thereof

The present invention relates to a recombinant vaccinia virus in which the expression of some genes is inhibited, and a use thereof. The recombinant vaccinia virus of the present invention selectively kills cancer cells, and has an excellent reproducibility in cancer cells. Also, the virus has a lower toxicity to normal cells, and thus has an advantage of being safe for a human body. Therefore, the recombinant vaccinia virus of the present invention can be effectively used as a composition for treating cancer.

COMPOSITION FOR ALLEVIATING OR TREATING PAIN

The present invention relates to a composition for alleviating or treating pain. A pharmaceutical composition of the present invention contains two or more selected from the group consisting of GAD, IL-10, and a gene encoding GDNF. The pharmaceutical composition of the present invention exhibits an excellent analgesic effect at a dosage lower than that of individual administration since genes are coadministered, and thus conventional side effects and toxicity can be reduced. Therefore, the pharmaceutical composition of the present invention can be useful in alleviating or treating pain. 1. A pharmaceutical composition comprising two or more selected from the group consisting of a gene encoding glutamate decarboxylase (GAD) , a gene encoding interleukin-10 (IL-10) , and a gene encoding a glial cell-derived neurotrophic factor (GDNF).2. The pharmaceutical composition of claim 1 , wherein the gene is in a form of being operably contained in a vector.3. The pharmaceutical composition of claim 2 , wherein the vector is at least one viral vector selected from the group consisting of adenovirus claim 2 , adeno-associated virus claim 2 , herpes simplex virus claim 2 , lentivirus claim 2 , retrovirus claim 2 , and poxvirus.4. The pharmaceutical composition of claim 2 , wherein the vector is at least one non-viral vector selected from the group consisting of a plasmid claim 2 , a lipo some claim 2 , a cationic polymer claim 2 , a micelle claim 2 , an emulsion claim 2 , and solid lipid nanoparticles.5. The pharmaceutical composition of claim 1 , wherein the GAD is GAD65 or GAD67.6. The pharmaceutical composition of claim 1 , wherein the gene encoding GAD is a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 1 claim 1 , SEQ ID NO: 4 claim 1 , SEQ ID NO: 32 claim 1 , SEQ ID NO: 34 or SEQ ID NO: 36.7. The pharmaceutical composition of claim 1 , wherein the gene encoding GAD is the nucleotide sequence of SEQ ID NO: 2 claim 1 , SEQ ID NO: 3 claim 1 , SEQ ID NO: 5 ...

NITROGEN-CONTAINING CYCLIC COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME

The present specification relates to a compound containing nitrogen, and a color conversion film, a backlight unit, and a display device, including the same. 2. The compound of claim 1 , wherein R1 to R8 are the same as or different from each other claim 1 , and are each independently hydrogen; deuterium; a halogen group; a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms; an aryl group having 6 to 30 carbon atoms claim 1 , which is unsubstituted or substituted with one or more selected from the group consisting of a halogen group claim 1 , a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted alkoxy group having 1 to 30 atoms claim 1 , a substituted or unsubstituted silyl group claim 1 , a substituted or unsubstituted aryl group having 6 to 30 carbon atoms claim 1 , and a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms; a silyl group which is substituted with an alkyl group; a carbazolyl group; a substituted or unsubstituted dihydroacridine group; a phenothiazine group; a phenoxazine group; or a dibenzofuranyl group claim 1 , or adjacent groups are bonded to each other to form one or more substituted or unsubstituted rings having 3 to 30 carbon atoms.3. The compound of claim 1 , wherein L1 and L2 are the same as or different from each other claim 1 , and are each independently an aryl group having 6 to 30 carbon atoms claim 1 , which is unsubstituted or substituted with one or more selected from the group consisting of a halogen group claim 1 , a cyano group claim 1 , a substituted or unsubstituted amine group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms claim 1 , a substituted or unsubstituted alkoxy group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted silyl group claim 1 , a substituted or ...

DISPLAY PANEL

A display panel includes: a substrate comprising a first area, a second area, and a third area between the first area and the second area; a stack structure in the second area and comprising a pixel electrode, an opposite electrode, and an intermediate layer between the pixel electrode and the opposite electrode; a groove in the third area and separating at least one organic material layer included in the intermediate layer; and at least one metal layer in the third area and comprising a first opening overlapping the groove, wherein the groove is defined in a multi-layered film including an organic layer and an inorganic layer on the organic layer, and the at least one metal layer is between the substrate and the multi-layered film. 1. A display panel comprising:a substrate comprising a first area, a second area, and a third area between the first area and the second area;a stack structure in the second area and comprising a pixel electrode, an opposite electrode, and an intermediate layer between the pixel electrode and the opposite electrode;a groove in the third area and separating at least one organic material layer included in the intermediate layer; andat least one metal layer in the third area and comprising a first opening overlapping the groove,wherein the groove is defined in a multi-layered film including an organic layer and an inorganic layer on the organic layer, and the at least one metal layer is between the substrate and the multi-layered film.2. The display panel of claim 1 , wherein the inorganic layer of the multi-layered film comprises a pair of tips protruding toward a center of the groove.3. The display panel of claim 2 , wherein the organic layer of the multi-layered film comprises an opening claim 2 , and the inorganic layer of the multi-layered film is in direct contact with the at least one metal layer through the opening of the organic layer.4. The display panel of claim 3 , wherein the inorganic layer of the multi-layered film comprises ...

NITROGEN-CONTAINING CYCLIC COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME

The present specification relates to a compound containing nitrogen, and a color conversion film, a backlight unit, and a display device, including the same. 2. The compound of claim 1 , wherein Ar1 and Ar2 are the same as or different from each other claim 1 , and are each independently an aryl group having 6 to 30 carbons atoms claim 1 , which is unsubstituted or substituted with at least one group selected from the group of fluorine claim 1 , a nitro group claim 1 , a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms claim 1 , a substituted or unsubstituted alkynyl group having 2 to 30 carbon atoms claim 1 , a substituted or unsubstituted silyl group claim 1 , a substituted or unsubstituted alkoxy group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted aryloxy group claim 1 , a substituted or unsubstituted amine group having 1 to 30 carbon atoms claim 1 , a substituted or unsubstituted aryl group having 6 to 30 carbon atoms claim 1 , and a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms.3. The compound of claim 1 , wherein Z is an aryl group having 6 to 30 carbon atoms claim 1 , which is unsubstituted or substituted with one or more selected from the group consisting of a halogen group claim 1 , a cyano group claim 1 , a silyl group claim 1 , a carboxyl group (COOH) claim 1 , a substituted or unsubstituted alkyl group claim 1 , a substituted or unsubstituted alkenyl group claim 1 , a substituted or unsubstituted alkoxy group claim 1 , a substituted or unsubstituted cycloalkyl group claim 1 , a substituted or unsubstituted sulfonyl group claim 1 , a substituted or unsubstituted aryloxy group claim 1 , and a substituted or unsubstituted aryl group; or a heteroaryl group having 2 to 30 carbon atoms claim 1 , which is unsubstituted or substituted with at least one group selected from the group of an alkyl group and an aryl ...

Composition for treating pain

A composition useful for alleviating or treating pain and uses thereof are disclosed. The composition containing glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine. A method for alleviating or treating pain of a subject includes administering the composition to the subject.

Composition comprising nucleic acid molecules encoding glutamate decarboxylase and il-10 for treating pain

The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.

Recombinant vaccinia virus and use thereof

The present invention relates to a recombinant vaccinia virus in which the expression of some genes is inhibited, and a use thereof. The recombinant vaccinia virus of the present invention selectively kills cancer cells, and has an excellent reproducibility in cancer cells. Also, the virus has a lower toxicity to normal cells, and thus has an advantage of being safe for a human body. Therefore, the recombinant vaccinia virus of the present invention can be effectively used as a composition for treating cancer.

Composition for treating pain

The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.

Composition for alleviating or treating pain

The present invention relates to a composition for alleviating or treating pain. A pharmaceutical composition of the present invention contains two or more selected from the group consisting of GAD, IL-10, and a gene encoding GDNF. The pharmaceutical composition of the present invention exhibits an excellent analgesic effect at a dosage lower than that of individual administration since genes are coadministered, and thus conventional side effects and toxicity can be reduced. Therefore, the pharmaceutical composition of the present invention can be useful in alleviating or treating pain.

Composition for alleviating or treating pain

N-phenyl-n'-phenoxycarbonyl-phenylsulfonhydrazide derivative and pharmaceutical composition comprising same

The present invention relates to a N -phenyl- N' -phenoxycarbonyl-phenylsulfonhydrazide derivative with excellent inhibitory activity on PGE 2 production, a method for preparing the same and a pharmaceutical composition comprising the same as an active ingredient. The present N -phenyl- N' -phenoxycarbonyl-phenylsulfonhydrazide derivative may be used effectively for preventing or treating inflammation, arthritis, high fever, pain, cancer, stroke or bone disease.

Display panel and display apparatus including the same

A display panel includes: a substrate including a first area, a second area, and a third area located between the first area and the second area; a display layer including a display element located in the second area; a first metal layer located in the third area; an organic insulating layer located on the first metal layer and including at least one contact portion; and a second metal layer located on the organic insulating layer and contacting the first metal layer through the at least one contact portion, in which the second metal layer has a first hole, and the organic insulating layer has a second hole or a first recess corresponding to the first hole, and a residual layer located in the second hole or the first recess and including a part of at least one organic layer overlaps the first metal layer.

Composition for treating pain

The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.

Display device with metal tip protruding toward groove center

A display panel includes: a substrate comprising a first area, a second area, and a third area between the first area and the second area; a stack structure in the second area and comprising a pixel electrode, an opposite electrode, and an intermediate layer between the pixel electrode and the opposite electrode; a groove in the third area and separating at least one organic material layer included in the intermediate layer; and at least one metal layer in the third area and comprising a first opening overlapping the groove, wherein the groove is defined in a multi-layered film including an organic layer and an inorganic layer on the organic layer, and the at least one metal layer is between the substrate and the multi-layered film.

Composition for preventing or treating degenerative brain diseases

The present invention relates to a composition for preventing or treating degenerative brain diseases. The pharmaceutical composition of the present invention contains at least two selected from the group consisting of an interleukin 10 (IL-10) protein or a gene encoding the same, a glial cell line-derived neurotrophic factor (GDNF) protein or a gene encoding the same, and a glutamate decarboxylase (GAD) protein or a gene encoding the same. Since the pharmaceutical composition of the present invention exhibits a better effect of alleviating and preventing degenerative brain diseases by co-administration of active ingredients than upon single administration, the pharmaceutical composition of the present invention can exhibit the same or higher effect only with a low concentration of the active ingredients. Therefore, the pharmaceutical composition of the present invention can be advantageously used for the prevention or treatment of degenerative brain diseases.

Recombinant vaccinia virus and use thereof

The present invention relates to a recombinant vaccinia virus in which the expression of some genes is inhibited, and a use thereof. The recombinant vaccinia virus of the present invention selectively kills cancer cells, and has an excellent reproducibility in cancer cells. Also, the virus has a lower toxicity to normal cells, and thus has an advantage of being safe for a human body. Therefore, the recombinant vaccinia virus of the present invention can be effectively used as a composition for treating cancer.

Citrus reticulata Blanco plant named ‘Tamdo No.3’

A new and distinct Citrus Reticulate Blanco plant named ‘Tamdo No. 3’, characterized by its upright plant type and strong vigor, The plant type of ‘Tamdo No.3’ is upright and the tree vigor is strong, fruit shape is oblate and the fruit shape index is about 143, fruit skin thickness is about 2.7 mm so it is easy skinning, the fruit flesh rate is about 82.9%, sugar of fruit juice is about 13.7° Bx, the acidity is about 0.79%, and the sugar acid ratio is about 17.34.

Semiconductor package including connection layer

A semiconductor package includes a first semiconductor package and a second semiconductor package on the first semiconductor package. The first semiconductor package includes a lower redistribution substrate, a connection substrate on the lower redistribution substrate, the connection substrate includes a through hole, a first insulating layer and a through via penetrating the first insulating layer, a lower semiconductor chip in the through hole, a connection layer between the connection substrate and the lower redistribution substrate, the connection layer includes a first metal pattern and a solder pattern on the first metal pattern, a first molding layer on the lower semiconductor chip and the connection substrate, and an upper redistribution substrate on the first molding layer. The second semiconductor package includes a package substrate, an upper semiconductor chip on the package substrate, and a second molding layer on the package substrate and the upper semiconductor chip.

Display panel including area for component inside display area and display apparatus including the same

A display panel includes: a substrate including a first area, a second area, and a third area located between the first area and the second area; a display layer including a display element located in the second area; a first metal layer located in the third area; an organic insulating layer located on the first metal layer and including at least one contact portion; and a second metal layer located on the organic insulating layer and contacting the first metal layer through the at least one contact portion, in which the second metal layer has a first hole, and the organic insulating layer has a second hole or a first recess corresponding to the first hole, and a residual layer located in the second hole or the first recess and including a part of at least one organic layer overlaps the first metal layer.

Method of manufacturing an integrated circuit device

An integrated circuit device including a substrate including first and second device regions; a first fin active region on the first device region; a second fin active region on the second device region; an isolation film covering side walls of the active regions; gate cut insulating patterns on the isolation film on the device regions; a gate line extending on the fin active regions, the gate line having a length limited by the gate cut insulating patterns; and an inter-region insulating pattern on the isolation film between the fin active regions and at least partially penetrating the gate line in a vertical direction, wherein the inter-region insulating pattern has a bottom surface proximate to the substrate, a top surface distal to the substrate, and a side wall linearly extending from the bottom to the top surface.

Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same

The present invention relates to a cross-linking agent compound of which end functional group is substituted with a protection group of a specific structure, a liquid crystal alignment composition comprising the cross-linking agent compound and polymer containing repeat units of polyimide or a precursor thereof, a method of preparing liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display using the same.

Composição para prevenir ou tratar doenças cerebrais degenerativas

composição para prevenir ou tratar doenças cerebrais degenerativas. a presente invenção refere-se a uma composição para prevenir ou tratar doenças cerebrais degenerativas. a composição farmacêutica da presente invenção contém, pelo menos, dois selecionados a partir do grupo consistindo em uma proteína de interleucina 10 (il-10) ou um gene que codifica a mesma, uma proteína de fator neurotrófico derivada de linhagem celular glial (gdnf) ou um gene que codifica a mesma, e uma proteína glutamato descarboxilase (gad) ou um gene que codifica a mesma. uma vez que a composição farmacêutica da presente invenção exibe um melhor efeito de aliviar e prevenir doenças cerebrais degenerativas por coadministração de ingredientes ativos do que por administração única, a composição farmacêutica da presente invenção pode exibir o mesmo efeito ou maior apenas com uma concentração baixa dos ingredientes ativos. portanto, a composição farmacêutica da presente invenção pode ser vantajosamente utilizada para a prevenção ou tratamento de doenças cerebrais degenerativas.

Diamine compound, and polyimide precursor and polyimide film using same

Disclosed is a novel diamine compound in which an imide ring is directly bonded to a (hetero)aryl ring in a molecule, and a polyimide film prepared by polymerizing the novel diamine compound exhibits improved thermal properties and storage stability.

Electronic device and controlling method of electronic device

An electronic device and a control method of an electronic device are provided. The method acquiring a plurality of images through at least one camera, inputting red green blue (RGB) data for each of the plurality of images into a first neural network model to obtain two-dimensional pose information on an object included in the plurality of images, inputting RGB data for at least one image of the plurality of images into a second neural network model to identify whether the object is transparent, if the object is a transparent object, performing stereo matching based on the two-dimensional pose information on each of the plurality of images to obtain three-dimensional pose information on the object, and if the object is an opaque object, acquiring three-dimensional pose information on the object based on one image of the plurality of images and depth information corresponding to the one image.

Dynamic cell culture platform for combinatorial and biomechanical stimulation

Described herein are apparatuses and methods for culturing and monitoring cells in dynamic physiological conditions with combinatorial and biomechanical stimulation. In some embodiments, the apparatuses and methods may comprise one or more cell culture chambers, flexible membranes, pneumatic actuators, microfluidic layers, or hydrogels. In some embodiments, various mechanical stimuli including bending stress, shear stress, or a combination thereof may be applied to one or more cell types. Also described herein are high-throughput and dynamic cell culture array systems comprising the described apparatuses and methods.

接合基板及びその製造方法

【課題】本発明は、接合基板及びその製造方法に関し、より詳細には、表面粗さが改善された接合基板及びその製造方法に関する。 【解決手段】このために、本発明は、基板；前記基板上に接合され、前記基板と化学組成が異なる薄膜層；及び、前記基板と前記薄膜層との間に配置され、前記薄膜層との接合部界面で発生するボイド（ｖｏｉｄ）の移動性を増加させて、前記薄膜層の表面が前記ボイドにより突出することを防止する中間層を含むことを特徴とする接合基板を提供する。 【選択図】図１

Electronic device and control method of electronic device

Citrus reticulata Blanco plant named ‘Tamdori’

A new and distinct Citrus reticulate Blanco plant named ‘Tamdori’, characterized by its upright plant type and strong vigor, fertile but self-incompatibility pollen, orange fruit color, germination stage in middle of April, blooming state in late May, fruits start coloring in late October and finish coloring in late December, mature stage in middle of February, fruit weight at about 168.9 g, fruit skin thickness at about 2.3 mm and easy to peel, fruit flesh rate at about 79.9%.

Diamine compound, and polyimide precursor and polyimide film using same

Disclosed is a novel diamine compound in which an imide ring is directly bonded to a (hetero)aryl ring in a molecule, and a polyimide film prepared by polymerizing the novel diamine compound exhibits improved thermal properties and storage stability.

Diamine compound, and polyimide precursor and polyimide film using same

Use of virus-like particles including toxoplasma gondii apical membrane antigen 1 for serodiagnosing toxoplasmosis

The present disclosure relates to a use of virus-like particles including Toxoplasma gondii apical membrane antigen 1 for serodiagnosing toxoplasmosis, wherein an enzyme-linked immunosorbent assay with an infected serum was conducted using virus-like particles expressing Toxoplasma gondii AMA1, and higher sensitivity than the existing Toxoplasma gondii antigen was observed using virus-like particles, and no false diagnosis such as false negatives and false positives appeared after a reaction with a malaria-infected serum and thus high specificity was identified.

Semiconductor device including a field effect transistor and method of fabricating the same

Disclosed are semiconductor devices and their fabricating methods. The semiconductor device comprises first and second active patterns, a first channel pattern including first semiconductor patterns, a second channel pattern including second semiconductor patterns, a gate electrode on the first and second channel patterns, and a gate dielectric layer between the gate electrode and the first and second channel patterns. The gate electrode includes a first inner gate electrode between the first semiconductor patterns, a second inner gate electrode between the second semiconductor patterns, and an outer gate electrode outside the first and second semiconductor patterns. The first and second inner gate electrodes are on bottom surfaces of uppermost first and second semiconductor patterns. The outer gate electrode is on top surfaces and sidewalls of the uppermost first and second semiconductor patterns. The first and second inner gate electrodes have different work functions.

Nichtflüchtige halbleiterspeichereinrichtung und verfahren zum herstellen derselben

Halbleitereinrichtung, umfassend einen ersten Source-Bereich und einen Drain-Bereich, die auf einem Substrat angeordnet sind; einen ersten Gate-Stapel, der ein erstes Floating-Gate und ein erstes Steuer-Gate umfasst und zwischen dem ersten Source-Bereich und dem Drain-Bereich angeordnet ist; ein erstes Auswahl-Gate, das auf einer Seitenwand des ersten Gate-Stapels angeordnet ist; einen ersten Abstandshalter, der auf einer unteren Seitenwand des ersten Auswahl-Gates angeordnet ist und angrenzend an den ersten Source-Bereich angeordnet ist; einen zweiten Abstandshalter, der auf einer oberen Seitenwand des ersten Auswahl-Gates angeordnet ist; eine erste Steuergate-Silizidschicht, die auf dem ersten Steuer-Gate angeordnet ist; und eine erste Auswahl-Gate-Silizidschicht, die auf dem ersten Auswahl-Gate angeordnet ist und zwischen dem ersten Abstandshalter und dem zweiten Abstandshalter angeordnet ist.

Robot and control method therefor

A robot is provided. The robot includes a depth camera, a light detection and ranging (LIDAR) sensor, and at least one processor, wherein the at least one processor acquires a first depth image including first depth information by using the depth camera, acquires second depth information corresponding to a first area of the first depth image by using the LIDAR sensor, acquires a depth difference between the second depth information and the first depth information included in the first area, identifies an area to be corrected around the first area, acquires information regarding a filter for correcting the first depth information on the basis of the depth difference, and acquires a second depth image by correcting the first depth information corresponding to the area to be corrected, on the basis of the first depth information, the second depth information, and the information regarding the filter.

Method of manufacturing an integrated circuit device

An integrated circuit device including a substrate including first and second device regions; a first fin active region on the first device region; a second fin active region on the second device region; an isolation film covering side walls of the active regions; gate cut insulating patterns on the isolation film on the device regions; a gate line extending on the fin active regions, the gate line having a length limited by the gate cut insulating patterns; and an inter-region insulating pattern on the isolation film between the fin active regions and at least partially penetrating the gate line in a vertical direction, wherein the inter-region insulating pattern has a bottom surface proximate to the substrate, a top surface distal to the substrate, and a side wall linearly extending from the bottom to the top surface.

Recombinant vaccinia virus and use thereof

Display device

A display device including: a display module; a color filter layer disposed on the display module; and a window panel disposed on the color filter layer, wherein the window panel includes a glass substrate adjacent to the color filter layer, and an optical layer disposed on the glass substrate and having a reflectance of about 1.08% to about 5.00%, wherein the optical layer includes a base layer adjacent to the glass substrate, a first functional layer disposed on the base layer, wherein the first functional layer includes a hard coating agent and an anti-static agent, and a second functional layer disposed on the first functional layer, wherein the second functional layer includes a fluorine-containing silane compound.

Vírus vaccinia recombinante, composição farmacêutica que compreende o dito vírus e uso do mesmo para prevenir ou tratar câncer

A presente invenção refere-se a um vírus vaccinia recombinante, no qual a expressão de alguns genes é inibida, e um uso do mesmo. O vírus vaccinia recombinante da presente invenção elimina seletivamente células cancerosas e possui uma excelente reprodutibilidade em células cancerosas. Além disso, o vírus apresenta uma menor toxicidade para as células normais e, portanto, possui a vantagem de ser seguro para o corpo humano. Por conseguinte, o vírus vaccinia recombinante da presente invenção pode ser utilizado de forma eficaz como uma composição para o tratamento do câncer.

Display panel

A display panel includes: a substrate comprising a first area, a second area, and a third area between the first area and the second area; a stack structure in the second area and comprising a pixel electrode, an opposite electrode, and an intermediate layer between the pixel electrode and the opposite electrode; a groove in the third area and separating at least one organic material layer included in the intermediate layer; and at least one metal layer in the third area and comprising a first opening overlapping the groove, wherein the groove is defined in a multi-layered film including an organic layer and an inorganic layer on the organic layer, and the at least one metal layer is between the substrate and the multi-layered film.

Electronic device having touch pad area and keyboard

Provided is an electronic device including: a display; a base part operably coupled to the display, having a keyboard region, and configured to detect a touch input, the base part having a touch pad region for detecting a touch input and a peripheral region surrounding the touch pad region and the keyboard region. The base part includes: a first region formed as a metal case made of a metal formed on the peripheral region; a second region where at least a portion of the metal case is removed to correspond to the touch pad region; and a coating layer disposed on an upper area of the first region and an upper area of the second region to hide a boundary line between the first region and the second region.

Semiconductor device including a field effect transistor and method of fabricating the same

Disclosed are semiconductor devices and their fabricating methods. The semiconductor device comprises first and second active patterns, a first channel pattern including first semiconductor patterns, a second channel pattern including second semiconductor patterns, a gate electrode on the first and second channel patterns, and a gate dielectric layer between the gate electrode and the first and second channel patterns. The gate electrode includes a first inner gate electrode between the first semiconductor patterns, a second inner gate electrode between the second semiconductor patterns, and an outer gate electrode outside the first and second semiconductor patterns. The first and second inner gate electrodes are on bottom surfaces of uppermost first and second semiconductor patterns. The outer gate electrode is on top surfaces and sidewalls of the uppermost first and second semiconductor patterns. The first and second inner gate electrodes have different work functions.

Organic light emitting diode display device and method of manufacturing the same

Discussed are an organic light emitting diode (OLED) display device and a method of manufacturing the same, which can simplify a manufacturing process and decrease an error. The OLED display device includes a substrate on which an organic light emitting diode (OLED) is formed, a first inorganic thin layer configured to cover the OLED, an organic deposition layer configured to have an organic layer characteristic covering the first inorganic thin layer, and a second inorganic thin layer configured to cover the organic deposition layer.